People · Operator
Named in public records as an officer, director or promoter · active 2008–2019 · Biotech, Biotechnology, Manufacturing, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CHD Bioscience, Inc. | — | Biotech | Series A | $18.7M | $3.3M | 2014 |
| Altea Therapeutics Corp | — | Biotechnology | Seed | $3.7M | $30.4M | 2009 |
| Chata Biosystems Inc | — | Manufacturing | Seed | $1.8M | $3.8M | 2008 |
| Race to Judgment, LLC | — | Other | Pre-Seed | $215K | $5.0M | 2019 |
Alan Smith at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Alan Smith on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Nelson | 2 | 3 |
| Douglas Coder | 2 | 2 |
| Michael Litwack | 2 | 2 |
| Dennis Templar | 2 | 2 |
| Theodore Ziemann | 2 | 2 |
| Brian Murphy | 1 | 15 |
| Anthony Evnin | 1 | 6 |
| Jesse I. Treu | 1 | 5 |
| Michael Handley | 1 | 4 |
| Anthony B. Evnin | 1 | 4 |
| Jesse Treu | 1 | 4 |
| Roy Carver, Jr. | 1 | 2 |
| William R. Good | 1 | 2 |
| Michael Hatch | 1 | 2 |
| Steven Damon | 1 | 2 |
| Harold Shlevin | 1 | 2 |
| Ruth Devenyns | 1 | 2 |
| Ed Neas | 1 | 1 |
| Alan Ruud | 1 | 1 |
| Loretta Mealy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.